Balance sheet - the Novozymes Group


Audited by PwC
Note Dec. 31, 2010   Dec. 31, 2009
      DKK million DKK million  
ASSETS
11 Intangible assets 1,070  1,124 
13 Property, plant and equipment 5,866  4,804 
14 Deferred tax assets 71  62 
15 Other financial assets   50   
Total non-current assets 7,057  5,991 
16 Inventories 1,640  1,535 
17 Trade receivables 1,772  1,468 
18 Tax receivables 232  210 
19 Other receivables 249  215 
15 Other financial assets 178  187 
Cash at bank and in hand   1,465  1,284   
Total current assets 5,536  4,899 
Total assets   12,593  10,890   
           
LIABILITIES AND SHAREHOLDERS' EQUITY
20 Common stock 650  650 
20 Treasury stock (1,479) (1,624)
Other reserves 540  154 
Retained earnings 8,113  6,651 
21 Minority interests   12  10   
Total shareholders' equity 7,836  5,841 
14 Deferred tax liabilities 493  694 
22 Long-term employee benefits 13  13 
23 Provisions 169  125 
24 Other financial liabilities   1,574  1,696   
Total non-current liabilities 2,249  2,528 
24 Other financial liabilities 291  632 
23 Provisions 50  30 
Trade payables 764  531 
18 Tax payables 86  97 
25 Other payables   1,317  1,231   
Total current liabilities 2,508  2,521 
         
Total liabilities 4,757  5,049 
Total liabilities and shareholders' equity 12,593  10,890   
My Report

0 pages added